Barclays analyst Benjamin Theurer upgraded Bunge (BG) to Overweight from Equal Weight with a price target of $120, up from $105. The firm says dilution from the Viterra merger is less than feared. Barclays is now confident in Bunge’s ability to drive better mid-cycle earnings. It sees the stock outperforming peers in 2026 amid additional vertical integration benefits.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BG: